Dedicated bifurcation stents or regular drug eluting stents in distal left main stenosis: A retrospective study

Adam Kern1, Robert J Gil, Krystian Bojko

  • 1Faculty of Medical Sciences University of Warmia and Mazury, Olsztyn, Poland. adamkern@mail.com.

Cardiology Journal
|July 18, 2017
PubMed

Insights

This study compared regular drug-eluting stents (rDES) and dedicated bifurcation stents for distal left main (LM) stenosis. Both stent types showed comparable rates of major adverse cardiovascular events (MACE) and target lesion revascularization (TLR) after 36 months.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Distal left main (LM) atherosclerosis commonly occurs at bifurcations or trifurcations.
  • Understanding treatment strategies for distal LM stenosis is crucial for patient outcomes.

Purpose of the Study:

  • To analyze treatment strategies for distal left main (LM) stenosis.
  • To evaluate clinical outcomes associated with different stent types in distal LM stenosis.

Main Methods:

  • A retrospective analysis of 102 patients with distal LM stenosis treated between June 2012 and June 2013.
  • Patients received either regular drug-eluting stents (rDES) or dedicated bifurcation stents (BiOSS LIM®).
  • Clinical outcomes, including major adverse cardiovascular events (MACE) and target lesion revascularization (TLR), were assessed at 12, 24, and 36 months.

Main Results:

  • 90 patients underwent percutaneous coronary intervention with no implantation failures.
  • After 36 months, the MACE rate was 19.0% (BiOSS: 18.8% vs. rDES: 19.2%) and the TLR rate was 10.7% (BiOSS: 12.5% vs. rDES: 9.6%).
  • Proximal optimization technique was associated with better TLR outcomes, while non-ST-elevation ACS, ST-elevation myocardial infarction, and side branch stenting were risk factors for poor outcomes.

Conclusions:

  • Both regular drug-eluting stents (rDES) and dedicated bifurcation BiOSS LIM® stents offer simple and effective treatment options for distal LM stenosis.
  • Comparable MACE and TLR rates were observed between the two stent types, suggesting similar long-term efficacy.
Abstract